B-40 clinical trial




















Reporting: Baseline and immediately after the 4-week intervention. Treatment: Varies. Frequently Asked Questions.

Ask the study coordinator a question. Other questions from users. Are there any geographic restrictions to consider when applying for this trial? Will my insurance cover participating in this trial? Book My Call. Measurement Requirements. See if you qualify for this trial. Interventional Clinical Trial. Estimated Enrollment :. Actual Study Start Date :. Estimated Primary Completion Date :. Estimated Study Completion Date :.

Huntington Beach, California, United States, Colorado Springs, Colorado, United States, Midwest Cardiovascular Research and Education Foundation. Northwell Health Phys. Partners Cardiology at Valley Stream. Burlington, North Carolina, United States, Buenos Aires, Ciudad Auton.

De Buenos Aires, Argentina, Caba, Ciudad Auton. Villa Luro, Ciudad Auton. Campina Grande do Sul, Parana, Brazil, Ambulatory facility for specialized outpatient medical care. Centre Integre de sante et de services sociaux de Lanaudiere.

Clinica Colsanitas S. A, Sede Clinica Universitaria Colombia. Greifswald, Mecklenburg-Vorpommern, Germany, Bad Oeynhausen, Nordrhein-Westfalen, Germany, Medifarma Egeszsegugyi, Kereskedelmi es Szolgaltato Kft.

Cheongju, Chungcheongbugdo, Korea, Republic of, Seongnam-si, Gyeonggido, Korea, Republic of, Alcaldia Gustavo A. Madero, Distrito Federal, Mexico, Consultorio de Medicina Especializada del Sector Privado. Centro de Estudios Clinicos de Queretaro S. Hospital Central "Dr. Ignacio Morones Prieto".

Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej. Samodzielny Publiczny Specjalistyczny Szpital Zachodni. Unicardia Specjalistyczne Centrum Leczenia Ch.

Serca i Naczyn. Wojewodzki Specjalistyczny Szpital im. Spitalul Clinic Municipal de Urgenta "Timisoara". Constantin Opris Baia Mare. Spitalul Clinic de Urgenta "Sf. Institute of Complex Cardiovascular Disorders. This results in scarring and a shortened cervix, which can cause problems during childbirth and lead to increased risk of caesarean section. In addition, women who have this procedure have a very high risk of developing cervical cancer over the next 20 years if they do not continue to be screened.

You're not home-free. With the vaccine, researchers found that it not only eliminated the lesions but also eliminated the HPV infection. Women who received the vaccine injections reported sometimes-severe reactions at the injection site. Harper says that was expected, because the vaccine is designed to trigger the immune system. An immune reaction is likely to inflame the skin. The study looked only at cervical lesions, but HPV is linked to several other types of cancer, including head and neck cancer and anal cancer.

The researchers envision testing TS for these cancers in the future. Additional clinical trials are needed before seeking approval for TS from the U. S Food and Drug Administration. No trials are currently available. Materials provided by Michigan Medicine - University of Michigan. Note: Content may be edited for style and length. Science News. Journal Reference : Diane M.



0コメント

  • 1000 / 1000